Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.29 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.29 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.29 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.29 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.29 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.29 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ML.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ML.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ML.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ML.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ML.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ML.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ML.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ML.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.283EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.283EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.283ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.283ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.283EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.283EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.283ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.283ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.205EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.205ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.205ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.205EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.205EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.205ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.205ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.110EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.110ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.110ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used